High-throughput Single Cell Co-assay of Histone Modifications and Transcriptome
Award amount
$350,000Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- EPIGENOME TECHNOLOGIES, INC.
- Proposal award date
- 2021-09-15
- Contract end date
- 2022-08-31
- UEI
- LS7JQN77JKQ1
- Solicitation number
- PA20-025
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Single-cell Epigenome Analysis of the Alzheimer's Disease Brain
- High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome
- Single-cell Epigenome Analysis of the Alzheimer's Disease Brain
- Broadly Accessible Technologies for Single-cell Joint Analysis of Transcriptome and Epigenome
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
5 SBIR/STTR records share this UEI (2021–2024). Reported award amounts total $5,662,517. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services